Gene · 57192
Papers1,559
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,559
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EXPRESS: A Road to Recovery: Transient Receptor Potential (TRP) Channels as Therapeutic Avenues for Spinal Cord Injury. | Mol Pain | 2026 | 41622145 | PubTator, text mining | PubMed |
| A perilysosomal feedforward mechanism regulates starvation-induced calcium signaling. | FEBS J | 2026 | 41542926 | PubTator, text mining | PubMed |
| Tmem110 regulates the conformation of TRPML1 to maintain endolysosomal homeostasis and prevent mitochondrial DNA leakage and pathological self-DNA processing. | Nat Commun | 2026 | 41540067 | PubTator, text mining | PubMed |
| Inactive ryanodine receptors sustain lysosomal availability for autophagy by promoting ER-lysosomal contact site formation. | Nat Commun | 2026 | 41540008 | PubTator, text mining | PubMed |
| Organelle-specific regulation of ferroptosis. | Biol Direct | 2026 | 41484993 | PubTator, text mining | PubMed |
| Differential ion selectivity and disease-associated dysfunction of TRPML channels revealed by patient and engineered mutants. | J Biol Chem | 2026 | 41260338 | PubTator, text mining | PubMed |
| OR2T6 modulates autophagy through the PPP3CA-mediated pathways to suppress gastric cancer. | Cell Death Differ | 2026 | 41214150 | PubTator, text mining | PubMed |
| Metformin alleviates ribociclib-induced lung injury by restoring impaired autophagy via targeting Mucolipin-1. | Toxicol Appl Pharmacol | 2026 | 41207516 | PubTator, text mining | PubMed |
| Exploring the impact of variations in the mucolipin1 protein that result in mucolipidosis type 4 using the technique of molecular docking and dynamics simulation. | J Biomol Struct Dyn | 2026 | 39671793 | PubTator, text mining | PubMed |
| The ion transport, GPCR, and RTK toolkit expression in the human cerebrovascular endothelial cell line, hCMEC/D3: an Omics perspective. | Front Physiol | 2025 | 41488927 | PubTator, text mining | PubMed |
| A novel Bi-Allelic pathogenic MCOLN1 variant underlying mucolipidosis type IV in an Iranian family: clinical, genetic, and molecular dynamics-based structural analysis. | BMC Med Genomics | 2025 | 41430707 | PubTator, text mining | PubMed |
| Overcoming ELDR-mediated cancer cell survival in vitro and in vivo via sphingomyelin-driven TRPML1 inactivation and TFEB suppression through lysosomal HSP70 targeting. | Pharmacol Res | 2025 | 41352406 | PubTator, text mining | PubMed |
| Protocol for genetic discovery and fine-mapping of multivariate latent factors from high-dimensional traits. | STAR Protoc | 2025 | 41241937 | PubTator, text mining | PubMed |
| Palmitate impairs autophagic degradation via oxidative stress/perilysosomal Ca2+ overload/mTORC1 activation pathway in pancreatic β cells. | JCI Insight | 2025 | 41217849 | PubTator, text mining | PubMed |
| Metabolic cell deaths in head and neck cancer: mechanisms, therapeutic potential, and challenges. | Ann Med | 2025 | 41185600 | PubTator, text mining | PubMed |
| The expression of MCOLN1 in preeclampsia maintains the balance of autophagy and pyroptosis induced by reactive oxygen species. | J Reprod Immunol | 2025 | 41161141 | PubTator, text mining | PubMed |
| Extracellular vesicles in metabolic perspective: mechanism and targeted therapy. | J Nanobiotechnology | 2025 | 41084004 | PubTator, text mining | PubMed |
| Membrane-Assisted Electrochemical Removal of Mg2+ and Ca2+ from Lithium Brines: Effects of Temperature and Current Density Through a Zeta Potential Approach. | Membranes (Basel) | 2025 | 41002885 | PubTator, text mining | PubMed |
| Conceptual development and implementation of a digital twin model for managing saltwater intrusion of an island coastal aquifer. | Environ Monit Assess | 2025 | 40999269 | PubTator, text mining | PubMed |
| Nortriptyline Inhibits Lysosomal Exocytosis-Mediated SASP During Gastric Cancer Progression via Targeting HOXA1-PITX2 Phase Separation. | Adv Sci (Weinh) | 2025 | 40995693 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57192/papers?page=3